Economic Evaluation of Different Systems for Cataract Surgery and Anesthesia

Ophthalmology Clinics of North America

Volumn 19, Issue 2, 2006, Pages 309-315

  Frick, Kevin D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIA INDUCTION; CATARACT; CATARACT EXTRACTION; CLINICAL RESEARCH; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; ECONOMIC ASPECT; OPERATING ROOM; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; SENSITIVITY ANALYSIS; VISUAL ANALOG SCALE;

ANESTHESIA; CATARACT EXTRACTION; COST-BENEFIT ANALYSIS; HUMANS; MODELS, ECONOMIC; UNITED STATES;

EID: 33646401789     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2006.02.013     Document Type: Review

References (20)

1. Tunis S.R. Economic analysis in healthcare decisions. Am J Manag Care 10 5 (2004) 301-304
2. Neumann P.J. Why don't Americans use cost-effectiveness analysis?. Am J Manag Care 10 5 (2004) 308-312
3. Brown M.M., and Brown G.C. Value based medicine. Br J Ophthalmol 88 8 (2004) 979
4. Kymes S.M., and Frick K.D. Value based medicine. Br J Ophthalmol 89 5 (2005) 643-644 [author reply 644]
5. Frick K., Kymes S., and Jacobson G. Cost-effectiveness: how do we avoid making a difficult science incomprehensible?. Ophthalmic Epidemiol 11 5 (2004) 331-335
6. In: Gold M.R., Siegel J.E., Russell L.B., et al. (Eds). Cost effectiveness in health and medicine (1996), Oxford University Press, New York
7. Mauskopf J.A., Paul J.E., Grant D.M., et al. The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 13 3 (1998) 277-288
8. In: Tolley G., Kenkel D., and Fabian R. (Eds). Valuing health for policy (1994), The University of Chicago Press, Chicago
9. Haddix A.C., Teutsch S.M., and Corso P.S. Prevention effectiveness: a guide to decision analysis and economic evaluation (2003), Oxford University Press, New York
10. US Department of Health and Human Services. Healthy people 2010. With understanding and improving health and objectives for improving health. 2 vols. 2nd edition (2000), US Government Printing Office, Washington, DC
11. Reeves S.W., Friedman D.S., Fleisher L.A., et al. A decision analysis of anesthesia management for cataract surgery. Am J Ophthalmol 132 4 (2001) 528-536
12. Stein J.D. Disparities between ophthalmologists and their patients in estimating quality of life. Curr Opin Ophthalmol 15 3 (2004) 238-243
13. Nease R.F., Whitcup S.M., Ellwein L.B., et al. Utility-based estimates of the relative morbidity of visual impairment and angina. Ophthalmic Epidemiol 7 3 (2000) 169-185
14. Brown M.M., Brown G.C., Sharma S., et al. Utility values associated with blindness in an adult population. Br J Ophthalmol 85 3 (2001) 327-331
15. Kraemer K.L., Roberts M.S., Horton N.J., et al. Health utility ratings for a spectrum of alcohol-related health states. Med Care 43 6 (2005) 541-550
16. Busbee B.G., Brown M.M., Brown G.C., et al. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 109 3 (2002) 606-612
17. Busbee B.G., Brown M.M., Brown G.C., et al. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 110 12 (2003) 2310-2317
18. Greiner R.A. Cost of care for patients with age-related macular degeneration in Switzerland and cost-effectiveness of treatment with verteporfin therapy. Semin Ophthalmol 16 4 (2001) 218-222
19. Tarn Y.H., and Smith M.D. Pharmacoeconomic guidelines around the world. ISPOR CONNECTIONS 10 4 (2004) 5-15
20. Ubel P.A., Hirth R.A., Chernew M.E., et al. What is the price of life and why doesn't it increase at the rate of inflation?. Arch Intern Med 163 14 (2003) 1637-1641